| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Reovirus-based therapy for cancer. | Expert Opin Biol Ther | 2009 | 1.11 |
| 2 | Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts. | Cancer Biol Ther | 2004 | 0.97 |
| 3 | Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel. | Invest New Drugs | 2011 | 0.82 |
| 4 | In vitro assessment of nucleoside analogs in multiple myeloma. | Cancer Chemother Pharmacol | 2004 | 0.78 |